Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3fln | 3FN | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.748 | |
| 3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.720 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.681 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.678 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.671 | |
| 3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.667 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.655 | |
| 3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.634 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.626 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.616 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.614 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.614 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.609 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.606 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.596 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.593 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.591 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.589 | |
| 3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.584 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.563 | |
| 2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.562 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.561 | |
| 4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.560 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.557 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.557 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.551 | |
| 4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.548 | |
| 2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.547 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.545 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.542 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.541 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.541 | |
| 3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.537 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.535 | |
| 3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.532 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.530 | |
| 2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.530 | |
| 4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.528 | |
| 5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.525 | |
| 3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.521 | |
| 1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.519 | |
| 3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.518 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.518 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.516 | |
| 4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.515 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.510 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.509 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.508 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.502 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.500 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.498 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.497 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.496 | |
| 4eh7 | 0OO | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 3o8t | BMU | Mitogen-activated protein kinase 14 | / | 0.493 | |
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.493 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.490 | |
| 3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.487 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.487 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.487 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.486 | |
| 1bl6 | SB6 | Mitogen-activated protein kinase 14 | / | 0.485 | |
| 3gw9 | VNI | Lanosterol 14-alpha-demethylase | / | 0.484 | |
| 3fl4 | FL4 | Mitogen-activated protein kinase 14 | / | 0.483 | |
| 4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.480 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.479 | |
| 3fkn | FKN | Mitogen-activated protein kinase 14 | / | 0.477 | |
| 4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.477 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.476 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.475 | |
| 4qmw | KS1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.475 | |
| 4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.474 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.472 | |
| 1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.471 | |
| 3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.471 | |
| 3sa0 | NRA | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.470 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.469 | |
| 1nzd | UPG | DNA beta-glucosyltransferase | / | 0.469 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.469 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.469 | |
| 2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
| 2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.468 | |
| 3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.468 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.468 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.467 | |
| 1xl5 | 190 | Gag-Pol polyprotein | 3.4.23.16 | 0.466 | |
| 1ywn | LIF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.466 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.466 | |
| 3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.466 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.466 | |
| 1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.465 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
| 2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.464 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.464 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.464 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.464 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.464 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
| 4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.463 | |
| 2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
| 2znq | 401 | Peroxisome proliferator-activated receptor delta | / | 0.462 | |
| 3bv3 | P39 | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.461 | |
| 4h4u | NDP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.461 | |
| 1iwi | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.460 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.460 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.460 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.460 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.459 | |
| 3gc7 | B45 | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.459 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.459 | |
| 4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.459 | |
| 3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.458 | |
| 4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.458 | |
| 1phe | PIY | Camphor 5-monooxygenase | 1.14.15.1 | 0.457 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.457 | |
| 2j5x | GSP | ADP-ribosylation factor 6 | / | 0.457 | |
| 2vyn | NAD | Glyceraldehyde-3-phosphate dehydrogenase A | / | 0.457 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.457 | |
| 4h50 | NAP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.457 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.457 | |
| 1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.456 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.456 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.456 | |
| 2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.456 | |
| 4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
| 4c8b | 0LI | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.456 | |
| 1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 1m7q | DQO | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.455 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.455 | |
| 3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.455 | |
| 4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.455 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.455 | |
| 1vik | BAY | Gag-Pol polyprotein | / | 0.454 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.454 | |
| 1dz6 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.453 | |
| 2gtm | LID | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 4erk | OLO | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.453 | |
| 4m69 | ANP | Receptor-interacting serine/threonine-protein kinase 3 | 2.7.11.1 | 0.453 | |
| 1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 3dey | DHT | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.452 | |
| 3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.452 | |
| 3klm | DHT | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.452 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.452 | |
| 3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.452 | |
| 1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 2nmt | NHM | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.451 | |
| 2q9f | C3S | Cholesterol 24-hydroxylase | / | 0.451 | |
| 4bdi | HAU | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.451 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.451 | |
| 4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.451 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
| 4kky | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.451 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.451 | |
| 1cde | GAR | Phosphoribosylglycinamide formyltransferase | / | 0.450 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
| 2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
| 3fmj | FMJ | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 3tuc | FPW | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.450 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.450 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.450 | |
| 1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.449 | |
| 1t87 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
| 2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
| 2fto | CB3 | Thymidylate synthase | / | 0.449 | |
| 3hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.449 | |
| 4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.449 | |
| 4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.449 | |
| 1t88 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
| 2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.448 | |
| 3dga | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.448 | |
| 4g3j | VNT | Lanosterol 14-alpha-demethylase | / | 0.448 | |
| 5ecc | NAP | Dehydrofolate reductase type I | / | 0.448 | |
| 1cde | DZF | Phosphoribosylglycinamide formyltransferase | / | 0.447 | |
| 1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.447 | |
| 2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.447 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.447 | |
| 4z61 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.447 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.447 | |
| 1bdl | IM1 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 1boo | SAH | Modification methylase PvuII | 2.1.1.113 | 0.446 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
| 2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.446 | |
| 2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.446 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.446 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.446 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.446 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.446 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
| 2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.445 | |
| 3fwi | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
| 3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.445 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.445 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.445 | |
| 1c1d | NAI | Phenylalanine dehydrogenase | / | 0.444 | |
| 1fnn | ADP | ORC1-type DNA replication protein | / | 0.444 | |
| 1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
| 1idb | 0DO | Gag-Pol polyprotein | / | 0.444 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.444 | |
| 1k6v | XN2 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
| 2p9c | NAI | D-3-phosphoglycerate dehydrogenase | 1.1.1.95 | 0.444 | |
| 2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.444 | |
| 4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.444 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
| 4hnc | 0UT | Mandelate racemase | / | 0.444 | |
| 4kb8 | 1QO | Casein kinase I isoform delta | 2.7.11.1 | 0.444 | |
| 4kl9 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.443 | |
| 1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.443 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.443 | |
| 3pvu | QRW | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.443 | |
| 3zmm | F9J | Tyrosine-protein kinase JAK2 | / | 0.443 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.443 | |
| 1bxo | PP7 | Penicillopepsin-1 | 3.4.23.20 | 0.442 | |
| 1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
| 2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.442 | |
| 3dhe | AND | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.442 | |
| 3hzt | J60 | Calmodulin-like domain protein kinase isoform 3 | / | 0.442 | |
| 3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.442 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.442 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.441 | |
| 2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
| 3fc1 | 52P | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3l63 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 4c9o | CAM | Cytochrome P450 | / | 0.441 | |
| 4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
| 4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
| 4g3r | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
| 4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.441 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.441 | |
| 1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.440 | |
| 1x2h | LPA | Lipoate-protein ligase A | 6.3.1.20 | 0.440 | |
| 1xe5 | 5FE | Plasmepsin-2 | 3.4.23.39 | 0.440 | |
| 2b7a | IZA | Tyrosine-protein kinase JAK2 | / | 0.440 | |
| 2fsv | NAD | NAD(P) transhydrogenase subunit alpha part 1 | 1.6.1.2 | 0.440 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
| 2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.440 | |
| 2p3c | 3TL | Protease | / | 0.440 | |
| 2q7v | FAD | Thioredoxin reductase | / | 0.440 | |
| 2zax | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
| 2znp | K55 | Peroxisome proliferator-activated receptor delta | / | 0.440 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
| 3d7z | GK5 | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3g45 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.440 | |
| 3iqz | H4M | F420-dependent methylenetetrahydromethanopterin dehydrogenase | 1.5.98.1 | 0.440 | |
| 3nr4 | PYV | Abscisic acid receptor PYL2 | / | 0.440 | |
| 3wrm | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
| 4ien | COA | Putative acyl-CoA hydrolase | / | 0.440 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 5cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 |